UnitedHealth Group (NYSE:UNH) Shares Unloaded Rep. David Taylor

Representative David Taylor (R-Ohio) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on June 02nd, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on May 14th. The trade occurred in the Representative's "DAVID TAYLOR TRUST > SCHWAB JOINT BROKERAGE #1 (HOME GROWN)" account.

Representative David Taylor also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Installed Building Products NYSE: IBP on 5/15/2025.
• Purchased $1,001 - $15,000 in shares of Fifth Third Bancorp NASDAQ: FITB on 5/14/2025.
• Purchased $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 5/14/2025.
• Sold $15,001 - $50,000 in shares of UnitedHealth Group NYSE: UNH on 5/14/2025.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 5/13/2025.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 5/12/2025.
• Purchased $1,001 - $15,000 in shares of Salesforce NYSE: CRM on 5/12/2025.
• Purchased $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 3/27/2025.
• Purchased $1,001 - $15,000 in shares of Parker-Hannifin NYSE: PH on 3/10/2025.
• Purchased $1,001 - $15,000 in shares of JPMorgan Chase & Co. NYSE: JPM on 3/10/2025.

UnitedHealth Group Price Performance

Shares of UNH traded down $4.77 during trading hours on Thursday, reaching $295.61. The stock had a trading volume of 12,405,237 shares, compared to its average volume of 10,891,771. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company's 50-day moving average is $418.00 and its two-hundred day moving average is $488.12. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $268.16 billion, a PE ratio of 19.07, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the company earned $6.91 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.99%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is currently 35.18%.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO John F. Rex acquired 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last quarter. Company insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Robert W. Baird cut their target price on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Bank of America downgraded shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $428.43.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. Waycross Partners LLC increased its position in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after acquiring an additional 658 shares during the last quarter. Sherbrooke Park Advisers LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $515,000. Full Sail Capital LLC boosted its stake in UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after acquiring an additional 33 shares during the last quarter. Soros Fund Management LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $39,413,000. Finally, Silvercrest Asset Management Group LLC lifted its position in shares of UnitedHealth Group by 47.8% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock valued at $19,625,000 after buying an additional 12,550 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio's 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Taylor (Republican Party) ran for election to the U.S. House to represent Ohio's 2nd Congressional District. He won in the general election on November 5, 2024. David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor's career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.